Laurus Labs, a major player in the pharmaceutical and biotechnology space, has been gaining traction among investors due to its strong fundamentals and sectoral potential.

Sharekhan reiterates its BUY recommendation for Ipca Laboratories, revising the target price to Rs 1,765.

KRChoksey Research reiterates its BUY recommendation for Balaji Amines Ltd with a revised target price of Rs 2,328, reflecting a potential upside of 16.6% from the current market price of Rs 1,996.

Biocon Ltd, a leading biopharmaceutical company, has been given an "Accumulate" rating by Geojit Financial Services with a target price of Rs. 376.

Morningstar has reiterated a ‘Buy’ rating for AstraZeneca (NASDAQ: AZN) with a fair value estimate of $78 per share, which represents a potential upside from the current market price of $65.19.

Argus Research has reiterated a ‘Buy’ recommendation for Novo Nordisk (NVO), setting a target price of $140, which indicates a potential upside from its current trading price of $107.